Kestra Medical Technologies, Ltd. (KMTS) Gross Margin
- Gross margin · 12 months: Value 53.89%; Formula and calculation Gross profit / revenue. Period ending 2026-07-31..
Gross margin
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 53.89% | Gross profit / revenue. Period ending 2026-07-31. $57.51M ÷ $106.73M × 100 ≈ 53.89% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 57.51M USD | Gross Profit |
| Revenue | 106.73M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 49.22M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-07-31 | $57.51M | $106.73M | $49.22M | 53.89% |
| 2026-04-30 | $48.86M | $95.13M | $46.26M | 51.37% |
| 2026-01-31 | $40.81M | $83.72M | $42.91M | 48.75% |
| 2025-10-31 | $34.46M | $74.26M | $39.80M | 46.40% |
| 2025-07-31 | $28.86M | $66.40M | $37.54M | 43.46% |
| 2025-04-30 | $24.21M | $59.81M | $35.60M | 40.47% |
| 2025-01-31 | (m) | (m) | (m) | (m) |
| 2024-10-31 | (m) | (m) | (m) | (m) |
| 2024-07-31 | (m) | (m) | (m) | (m) |
| 2024-04-30 | $362.00K | $27.81M | $27.45M | 1.30% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |